Dr. Ara Hagop Dikranian, MD

Dr. Dikranian practices at Cabrillo Center for Rheumatic Disease APC in San Diego, California.

Dr. Dikranian's NPI, 1609962026, was assigned on October 4, 2006. Dr. Dikranian graduated from Keck School of Medicine of USC in 1995. Dr. Dikranian holds California license A62403.

Dr. Dikranian's primary practice is Cabrillo Center for Rheumatic Disease APC, at 5030 Camino De Siesta, San Diego, CA 92108 in San Diego County. The practice phone is (619) 334-4869.

Dr. Dikranian's primary practice is Cabrillo Center for Rheumatic Disease APC in San Diego, California. Dr. Dikranian is also affiliated with Sharp Memorial Hospital. The medical group on file is Cabrillo Center for Rheumatic Disease. Dmand AI also links Dr. Dikranian to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dikranian practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Dikranian's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Dikranian is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Dikranian's licenses on file in 2 states: California and Arizona.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, lupus, muscle disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Dikranian treats.

CMS data shows 1,620 Medicare services from Dr. Dikranian across 5 procedure codes in 2024, for 181 Medicare patients. Medicare paid $53,164 for them. Every service was in an office.

CMS counts 181 Medicare patients who saw Dr. Dikranian in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have arthritis, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dikranian's median patient age at 68, with 79% women.

In 2024, Dr. Dikranian wrote 2,356 Medicare Part D claims for 279 patients. 75% of them were for generic drugs. CMS names the drug for 2,033 of them, across 41 drugs with 11 or more claims each, at $4,207,737 in total drug cost. In 2023, CMS named 1,966 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 33 out of 100 for Dr. Dikranian for performance year 2024, reported as part of a group. Dr. Dikranian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Dikranian, published from 2013 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Arthritis, Rheumatoid, Antirheumatic Agents and Health Surveys. Dr. Dikranian has published most often in Rheumatol Ther. Dr. Dikranian's most frequent co-authors are Matthew Charles Baker, MD, Martin Jan Bergman, MD and Stanley Bruce Cohen, MD.

Dmand AI links Dr. Dikranian to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Arthritis, Rheumatoid and Rheumatic Diseases. GlaxoSmithKline sponsors the most, 2.

CMS Open Payments shows 5,375 general payments to Dr. Dikranian from 70 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Abbvie Inc. paid the most, $505,770. It also lists 7 research payments totaling $13,340 from 2020 to 2023.

Dr. Dikranian graduated from Keck School of Medicine of USC in 1995.

Dr. Dikranian is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.